[Form 4] Tempus AI, Inc. Insider Trading Activity
Theodore Leonsis, a director of Tempus AI, Inc. (TEM), reported the sale of Class A common stock on 08/26/2025. The Form 4 shows 20,000 shares were sold at a weighted average price of $75.83, with individual trade prices reported in a range from $75.72 to $76.00. After the reported transactions, the filing lists 66,756 shares beneficially owned indirectly through the Theodore J. Leonsis Revocable Trust and 15,511 shares beneficially owned directly. The Form 4 was signed by an attorney-in-fact on 08/28/2025 and includes a footnote offering to provide a breakdown of shares sold at each price within the stated range.
- Form 4 filed and signed, disclosing the insider sale in compliance with Section 16
- Footnote offers to provide a breakdown of the number of shares sold at each price in the stated range
- Reporting person disposed of 20,000 Class A shares on 08/26/2025
- Sale reduced the reporter's direct/indirect position to the reported balances (15,511 direct; 66,756 indirect)
Insights
TL;DR: Routine insider sale disclosed; transaction size and remaining holdings are explicitly reported.
The Form 4 documents a sale of 20,000 Class A shares by director Theodore Leonsis on 08/26/2025 at a weighted average price of $75.83. The filing clearly separates ownership post-transaction into 66,756 indirect shares (via revocable trust) and 15,511 direct shares. This is a standard Section 16 disclosure showing disposition of equity and current beneficial ownership. No derivative transactions or additional contextual financial metrics are provided in the filing.
TL;DR: Disclosure follows Section 16 requirements; record shows sale and identifies indirect ownership vehicle.
The filing identifies the reporting person, relationship to the issuer (Director), transaction date (08/26/2025), and provides a footnote on price range and weighted average. It also specifies the indirect ownership vehicle as the Theodore J. Leonsis Revocable Trust. The Form 4 is executed by an attorney-in-fact and includes the offered availability of per-price transaction details. The document contains no amendments or derivatives information.